Advancements and Applications of Focused Assessed Transthoracic Echocardiography: A Narrative Review.

BACKGROUND AND AIMS: Focused Assessed Transthoracic Echocardiography (FATE), developed by Dr. Erik Sloth in 1989, has become a key ultrasound technique for rapid bedside assessment of cardiac function. Its non-invasive nature, real-time imaging, and portability make it ideal for facilitating swift clinical decisions across various specialties. This review aims to explore the evolution of FATE, evaluate its current clinical applications, and discuss prospects, with a focus on training protocols, image interpretation, and the incorporation of emerging technologies.

METHODS

A narrative review of the literature was conducted, examining studies and guidelines related to the development, methodology, and implementation of the FATE protocol. Emphasis was placed on evidence regarding standard imaging views, training practices, and the integration of new technologies in clinical settings.

RESULTS

The FATE protocol utilizes standard echocardiographic views to enable the rapid detection of critical cardiac conditions such as cardiac tamponade, valvular dysfunction, and left ventricular failure. Its ease of use and effectiveness have led to widespread adoption in diverse settings, including resource-limited environments and by non-cardiologists. The review highlights improvements in training and image acquisition techniques while also noting challenges such as operator variability and the need for ongoing quality assurance. Emerging technologies, notably artificial intelligence and handheld ultrasound devices are beginning to expand FATE's diagnostic capabilities.

CONCLUSION

FATE is a versatile and effective tool for rapid cardiac assessment that continues to evolve with advancements in technology and training. Addressing challenges such as operator variability will be essential for maximizing its clinical utility. Future research should focus on refining these aspects to further enhance patient outcomes.